共 50 条
- [3] An evaluation of potential signals for ventricular arrhythmia and cardiac arrest with dolasetron, ondansetron, and granisetron in the FDA combined spontaneous reporting system/adverse event reporting system [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2005, 66 (05): : 409 - 419
- [5] An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System [J]. Drug Safety, 2020, 43 : 457 - 465
- [7] IN VIDEO, FDA URGES ADVERSE EVENT REPORTING [J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2021, 259 (03): : 223 - 223
- [8] Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data [J]. Drug Safety, 2013, 36 : 1117 - 1123